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http:WHAT THIS PAPER ADDS
This study has focused on the characteristics and management of hemothorax, occurring in a large cohort of
patients with thoracic aortic rupture, treated with TEVAR. It may contribute further insights into the man-
agement of ruptured descending thoracic aorta and into optimizing the post-operative risk stratiﬁcation after
urgent TEVAR. Furthermore, it is hoped it will lead to larger studies to optimize current practice on the best
management of hemothorax after TEVAR.Objectives: The aim was to describe and analyze the management of hemothorax (HTX) and the occurrence of
respiratory complications after endovascular repair of thoracic aortic rupture (TEVAR).
Methods: This was a multicenter study with retrospective analysis. Between November 2000 and December
2012, all patients with conﬁrmed HTX due to rupture of the descending thoracic aorta treated with TEVAR were
included. Respiratory function (acid base status, PaO2, PaCO2, lactate, and respiratory index) was monitored
throughout hospitalization. Primary endpoints were survival and post-operative respiratory complications.
Results: Fifty-six patients were treated. The mean age was 62  21 years (range 18e92 years). Etiology included
traumatic rupture (n ¼ 23, 41%), atherosclerotic aneurysm (n ¼ 20, 36%), Debakey type IIIa dissection (n ¼ 8,
14%), and penetrating aortic ulcer (n ¼ 5, 9%). The primary technical success of TEVAR was 100%. The in hospital
mortality rate was 12.5% (n ¼ 7). Hemothorax was drained in 21 (37.5%) cases. In hospital respiratory
complications occurred in 23 (41%) patients who required a longer intensive care unit stay (days 2.3  0.7 vs.
1.9  0.8, p ¼ .017), and hospitalization (26  17 vs. 19  17, p ¼ .021). Those who developed post-operative
respiratory complications had lower pre-operative PO2 values (mmHg, 80  24 vs. 91  21, p ¼ .012).
Respiratory complications and in hospital mortality did not differ among aortic pathologies (p ¼ .269 and p ¼ 1.0,
respectively), nor did in hospital mortality differ between patients with and without respiratory complications
(13% vs. 12%; p ¼ .990).
Conclusions: Thoracic aortic rupture still has a high mortality rate. Respiratory complications have not been
eliminated by endovascular repair. HTX evacuation may have had a positive inﬂuence on the survival in these
patients. Although traumatic and degenerative ruptures are two signiﬁcantly different scenarios, survival and
respiratory outcomes were similar and were not affected by the underlying aortic disease.
 2015 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Rupture of the descending thoracic aorta has traditionally
been treated by open graft replacement, with its associated
mortality and complication rates which remain disturbingly
high.1e3 More recently, thoracic endovascular aortic repair
(TEVAR) has proved to be an effective, less traumatic,
alternative for the treatment of all thoracic aortic pathol-
ogies; indeed several papers have advocated TEVAR as
the ﬁrst choice for the emergency treatment of thoracic
aortic catastrophes.4e7 Rupture of the thoracic aorta is
frequently associated with hemothorax (HTX); however, the
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until now, and there is still uncertainty on indication and
timing of its treatment.8e14 Hemothorax may lead to major
complications such as compression of the esophagus and/or
cardiovascular structures, respiratory insufﬁciency, and
infection. All these complications may compromise the
post-operative survival in an already critically ill subset of
patients.8 The purpose of this study was to analyze the
management of HTX in patients with descending thoracic
aortic rupture treated with TEVAR.MATERIALS AND METHODS
Study population
The study was designed as a multicenter retrospective study.
Between November 2000 and December 2012, all patients
presenting with rupture of the descending thoracic aorta and
HTX treated with TEVAR were identiﬁed and included in the
analysis. Thoraco-abdominal lesions were excluded. Clinical
and procedural data were collected prospectively and
recorded in a dedicated database. All patients underwent
pre-operative thoraco-abdominal computed tomography
(CT) scans. Intervention was performed in the operating
theatre, equipped to perform either open surgical or endo-
vascular procedures. General anesthesia and antibiotic pro-
phylaxis with a second generation cephalosporin was used in
all patients. Four different thoracic endografts (EGs) were
implanted: Excluder/TAG/C-TAG (W.L. Gore and Associates,
Flagstaff, AZ, USA), Talent/Valiant/Captivia (Medtronic
Vascular, Santa Rosa, CA, USA), TX-1/TX-2 (Cook, Bloo-
mington, IN, USA), and Relay (Bolton Medical, Sunrise, FL,
USA). Post-operatively, the patient was transferred to the
intensive care unit (ICU). In all patients, respiratory function
was monitored at admission and during hospitalization: acid
base status, PaO2, PaCO2, lactate, and the respiratory index
(PaO2/FiO2) were evaluated.
15 Evacuation of the HTX was
always discussed case by case by the operating team and the
intensive care unit (ICU) physicians; generally, HTX was
drained when the respiratory index (RI) was < 200 or when
signs of respiratory or cardiovascular impairment were
detected. The hemothorax was drained with a chest tube;
video assisted thoracoscopy or open thoracotomy which was
used selectively for complicated trapped HTX. Clinical and CT
scan follow up were performed at 1, 6, and 12 months after
the intervention, and annually thereafter.Deﬁnition
Thoracic aortic rupture was deﬁned as hemorrhage outside
the boundaries of the aorta. Hemothorax was considered as
any collection of blood in the pleural cavity, but isolated
peri-aortic/mediastinal hematoma suggestive for a con-
tained rupture was not counted as HTX. Comorbidities were
deﬁned according to the Society of Thoracic Surgeons Adult
Database deﬁnitions.16 On admission, hemorrhagic shock
was deﬁned as a combination of systolic blood pressure <
80 mmHg after ﬂuid resuscitation or need for a-amines,
tachycardia (> 110 bpm), anuria or urine output < 15 mL/hour, unconsciousness, or circulatory arrest.17 The HTX at its
point of greater thickness in the baseline CT was classiﬁed:
< 2 cm, 2e3 cm, > 3 cm. Delay was deﬁned as the time
interval between the diagnosis of aortic rupture/onset of
symptoms and the start of the intervention. Traumatic
aortic injury severity grading was classiﬁed accordingly to
the clinical practice guidelines of the Society for Vascular
Surgery (SVS).18 The operative risk proﬁle was estimated
according to the EuroSCORE.19 Operative outcomes were
classiﬁed following the ad hoc committee on TEVAR
reporting standards of the Society for Vascular Surgery/
American Association for Vascular Surgery (SVS/AAVS).20
Speciﬁcally, respiratory complications were deﬁned as
grade 1 if recovery was prompt with medical treatment,
grade 2 for prolonged hospitalization or intravenous anti-
biotics, and grade 3 for prolonged intubation, tracheotomy,
deterioration in pulmonary function, O2 dependence, or
fatal outcome. Primary endpoints were the evaluation of
survival and respiratory complications.Data analysis
Clinical data were recorded in Microsoft Excel (Microsoft
Corp, Redmond, WA, USA). Results are presented as
mean  SD for continuous variables, and number (per-
centage) for categorical variables. Continuous variables
were compared with the ManneWhitney U test, and cat-
egorical variables by the Fisher exact test. The survival rate
was estimated by means of the KaplaneMeier method with
the log-rank test. A p value < .05 was considered signiﬁ-
cant. Statistical analysis was computed with SPSS, release
20.0, for Windows (IBM SPSS Inc., Chicago, IL, USA).
RESULTS
General data
During the study period a total of 500 TEVARs for
descending thoracic aortic diseases were performed: 402
(81%) intact aortic lesions were treated; 42 (8%) were
ruptured or traumatic lesions without HTX. Rupture with
HTX was present in 56 (11%) cases: there were 40 (71%)
males. Mean age was 62  21 years (range 18e92 years).
Traumatic ruptures (n ¼ 23, 41%) were caused by blunt
injuries in all cases; a grade IV injury was present in all
cases. In particular, traumatic rupture involved the distal
aortic arch below the left subclavian artery (n¼ 9, 39%) and
the descending aorta (n ¼ 14, 61%). Non-traumatic rup-
tures were caused by atherosclerotic aneurysm (n ¼ 20,
36%), Debakey type IIIa dissection (n ¼ 8, 14%), and
penetrating aortic ulcer (n ¼ 5, 9%). Overall demographic
data, co-morbidities and risk factors are reported in Table 1.Operative data
Emergent TEVAR was performed in 19 (34%) cases: all but
three (5%) patients were treated within 3 hours of rupture
with a median delay of 1.5 hours (range 0.5e24). The
proximal landing zone was “zone 2” in 18 (32%) cases and
“zones 3 or 4” in 38 (68%). Primary technical and primary
Table 2. Comparative data of aortic pathology ruptures.
Variablea Traumatic Non-traumatic p
(n ¼ 23) (n ¼ 33)
Demographic data (%)
M : F 19 : 4 21 : 12 .145
Age (mean  SD) 46  20 74  11 < .001
IHD 3 (13) 13 (39) .039
Cardiac disease 0 (0) 7 (21) .034
COPD 4 (17) 12 (36) .145
Diabetes 1 (4) 11 (33) .009
AKI 0 (0) 8 (24) .016
Obesity (BMI > 30) 1 (4) 13 (39) .004
Operative risk
Shock (%) 13 (56.5) 6 (18) .004
EuroSCORE
(mean  SD)
8  2.5 10  4 .038
Respiratory parameters ( SD)
Acid base status 7.3  0.1 7.4  0.1 < .001
PO2 (mmHg) 93  23 82  22 .076
PCO2 (mmHg) 41  9 37  6 .050
Lactates (mEq/L) 3.3  2.5 2  1.4 .016
Hemothorax thickness (%)
< 2 cm 2 (9) 11 (33) .051
2e3 cm 3 (13) 11 (33) .119
> 3 cm 18 (78) 11 (33) < .001
Respiratory
index ( SD)
208  104 286  105 .008
AKI ¼ acute kidney injury; BMI ¼ body mass index;
CAD ¼ coronary artery disease; COPD ¼ chronic obstructive
pulmonary disease; Hb ¼ hemoglobin; ICU ¼ intensive care unit;
LHF ¼ left heart failure; LOS ¼ length of stay; SBP ¼ systolic
blood pressure.
a For numerical variables, mean  SD; for categorical variables,
number and percentages.
Table 3. Post-operative major complications.
Complication n (%) Treatment
Respiratory 23 (41)
Grade 1 8 (14)
Grade 2 8 (14)
Grade 3 7 (12.5)
Cardiovascular
Atrial ﬁbrillation 2 (3.5)
Ischemic colitis 1 (2) Hartman procedure
AVF malfunction 1 (2) vBCT stent
Miscellaneous
Paraplegia 1 (2)
AKI 1 (2) Temporary HD
Dysphagia 1 (2)
AVF ¼ arteriovenous ﬁstula; AKI ¼ acute kidney injury;
vBCT ¼ vein brachiocephalic trunk; HD ¼ hemodialysis.
Table 1. Demographic and presentation data.
Variablea All patients
Demographic data
M : F 40 : 16
Age (mean, years) 62  21
Risk factors (%)
CAD 16 (29)
COPD 16 (27)
Obesity (BMI > 30) 15 (27)
Diabetes 13 (23)
AKI 8 (14)
Valve disease/LHF 7 (13)
Operative risk
Shock (%) 19 (34)
EuroSCORE (mean, predicted mortality) 9  4 (35  23)
AKI ¼ acute kidney injury; BMI ¼ body mass index;
CAD ¼ coronary artery disease; COPD ¼ chronic obstructive
pulmonary disease; LHF ¼ left heart failure.
a For numerical variables, mean  SD; for categorical variables,
number and percentages.
610 G. Piffaretti et al.clinical success was obtained in all cases: open conversion
was not required. Mean operation time was 107  63 mi-
nutes (range 30e300; median 90 minutes) and the mean
aortic coverage was 200  9 mm (range 10e38; median
200 mm). Median blood loss was 200 mL (range 50e
2,600 mL) and mean blood transfusion was 4  4 units of
packed red blood cells (range 0e27; median, 4). ICU stay
was < 2 days in 13 (23%) cases, between 3 and 14 days in
24 (43%), and > 15 days in 19 (34%).
Hemothorax management
Left HTX was present in all cases and was bilateral in three
(5%). Hemothorax thickness on pre-operative computed
tomography angiography was < 2 cm in 13 (23%) cases,
between 2 and 3 cm in 13 (23%), and > 3 cm in 30 (54%).
Overall, HTX was drained in 21 (37.59%) cases: 1 of 13 (7%)
for HTX < 2 cm, 6 of 13 (46%) for HTX between 2 and 3 cm,
and 14 of 30 (47%) for HTX > 3 cm. All patients but one
were drained within the ﬁrst 3 post-operative days. A chest
tube was used in 16 (28%), and surgical evacuation in six
(11%). Co-morbidities and risk factors were similar in
drained and retained HTX, but drained patients showed
worst pre-operative levels of lactate (mEq/L, 3.1  2.3 vs.
1.8  1.0, p ¼ .028), PCO2 (mmHg, 41  9 vs. 36  5,
p ¼ .037), and post-operative RI (198  106 vs. 311  88,
p ¼ .001): in hospital mortality did not differ in these two
groups (18% vs. 6%, p ¼ .197). Although traumatic and non-
traumatic ruptures had signiﬁcantly different co-
morbidities, risk factors and respiratory status (Table 2),
the need of chest drainage (48% vs. 33%, p ¼ .838) did not
differ between the two groups.
Early outcomes
The aortic related mortality rate was 12.5% (n ¼ 7): causes
of death were shock (n ¼ 6, 11%) and respiratory failure
(n ¼ 1, 2%). Mean hospitalization was 21  16 days (range
2e83 days). TEVAR related complications are summarized in
Table 3. In particular, respiratory complications occurred in23 (41%) patients. Overall, no patients required deﬁnitive
tracheotomy; brieﬂy, those who developed post-operative
respiratory complications were older (63  21 vs.
62  21, p ¼ .012), had lower pre-operative PO2 values
(mmHg, 80  24 vs. 91  21, p ¼ .012), and worse RI at the
end of intervention (265  110 vs. 311  88, p ¼ .001). No
other signiﬁcant differences were observed (Table 4). Res-
piratory complications led to longer mechanical ventilation
(7  9 vs. 2  7 days, p ¼ .001), ICU stay (2.3  0.7 vs.
Hemothorax Management After Endovascular Treatment 6111.9  0.8 days, p ¼ .017), and hospitalization (296  21 vs.
17  12 days, p ¼ .009). Post-operatively, traumatic and
non-traumatic ruptures did not differ signiﬁcantly for pro-
longed (> 10 days) ventilation time (9% vs. 12%, p ¼ 1.0),
respiratory complications (30% vs. 48%, p ¼ .269), hospi-
talization (25  21 vs. 19  15 days, p ¼ .217), and in
hospital mortality (9% vs. 12%, p ¼ 1.0). In hospital mor-
tality did not differ between patients with and without
respiratory complications (13% vs. 12%; p ¼ .990).
Late outcomes
Forty-nine (87.5%) patients were discharged alive: 48 of 49
(86%) patients were available for follow up. Mean follow up
was 39  29 months (range 1e108; median 40 months).
TEVAR related re-intervention was never required. Nine
(19%) patients died during follow up (mean 24 months):
aortic related mortality was not observed, and the pre-
dominant cause of death was acute myocardial infarction
(n ¼ 4). Estimated overall survival was 85  4.8% at 3
months, 79  5.6% at 1 year, and 61  8.5% at 5 years.
DISCUSSION
Population based analysis and single center studies have
reported a signiﬁcant beneﬁt of TEVAR versus open repair
for peri-operative mortality, regardless of the indication for
repair and type of pathology.1,2,5e7 Nevertheless, peri-
operative mortality after TEVAR for thoracic aortic rupture
is still disturbingly high in the range of 8e30%.1,5,6,22e25 The
12.5% in hospital mortality rate is good if compared with
the 35.3% predicted pre-operatively, and it is consistentTable 4. Intra-operative and post-operative details with reference to p
Variablea All patients (n ¼ 56) N
Demographic data
M : F 40 : 16 2
Age (yrs) 63  21 6
Risk factors
CAD 16 (29) 8
Valve disease/LHF 7 (13) 1
COPD 16 (27) 7
Diabetes 13 (23) 8
AKI 8 (14) 5
Obesity (BMI > 30) 15 (27) 8
Aortic disease .3
Degenerative 33 (59) 1
Trauma 23 (41) 1
Operative risk
Shock 19 (34) 1
EuroSCORE (additive) 9  4 9
Preoperative parameters
Acid base status 7.4  0.1 7
PO2 (mmHg) 87  23 9
PCO2 (mmHg) 38  7 3
Lactates (mEq/L) 2.4  1.9 1
Hemothorax thickness > 3 cm 29 (52) 2
Respiratory index 265  110 3
AKI ¼ acute kidney injury; BMI ¼ body mass index; CAD ¼ coronary
Hb ¼ hemoglobin; LHF ¼ left heart failure; SBP ¼ systolic blood pres
a For numerical variables, mean  SD; for categorical variables, numbwith the average 19.4% emerging from previous published
series which have included all aortic pathologies as under-
lying causes of the thoracic aortic rupture.1,5,6,8,22,23 By
contrast, the long-term beneﬁt of TEVAR has been associ-
ated with conﬂicting results. Goodney et al.21 found that
patients selected for TEVAR had worse long-term survival
than patients selected for open repair. However, they
studied an aneurysm cohort only, and postulated that
TEVARs were offered to higher risk patients. The estimated
61% survival at 5 years in the present study is better than
the 26% reported by Goodney et al., and compares favor-
ably with other series (in the range 23e55%) which include
different aortic catastrophes.2,5,6,8,22e25 In an emergent
setting, the rapidity and minimal invasiveness of TEVAR may
be the preferred approach for patients who may not have
tolerated a complex and risky operation.
On admission, HTX has frequently been noted after
thoracic aortic rupture with an associated increased 30 day
mortality.1,8,9,14,22 Unfortunately, not all of the studies
described the treatment and fate of HTX after TEVAR. In
their multicenter study, Jonker et al.8 reported a 41.4% rate
of HTX on admission, and a six fold increased risk of in
hospital mortality when it was present after rupture of a
descending aneurysm; however, the management and
outcomes of HTX were not described. Only Shu et al.9 re-
ported the treatment of HTX after TEVAR. They drained 22%
(6/27) of the cases in order to improve respiratory function,
but included a cohort of complicated dissections only and
almost always used thoracocentesis to evacuate the pleural
hematoma. This study is substantially different: theost-operative respiratory complication.
o complication (n ¼ 33) Complicated (n ¼ 23) p
5 : 8 15 : 8 .55
2  21 64  21 .012
(24) 8 (35) .55
(3) 6 (26) .015
(21) 9 (39) .23
(24) 5 (22) .99
(15) 3 (13) .99
(24) 7 (30) .76
1
7 (52) 16 (70)
6 (48) 7 (30)
0 (30) 9 (39) .57
 3 10  4 .44
.3  0.1 7.4  0.1 .99
1  21 80  24 .012
6  5 40  9 .13
.8  1.3 3.1  2.3 .53
0 (61) 9 (39) .17
11  88 198  106 .001
artery disease; COPD ¼ chronic obstructive pulmonary disease;
sure.
er and percentages.
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either chest tube or open surgery was used. These data may
be explained by the fact that only patients with HTX on the
baseline CT scan were included, and they underscore the
different severity of the HTX in these cases. Nevertheless,
this study agrees with that of Shu et al. that prompt
drainage should be performed to improve respiratory
function and survival. The aggressive approach may have
been a contributing factor to explain the fact that the
mortality rate of patients who needed drainage of their HTX
was not different from those that were not drained, despite
a more critical pre-operative respiratory condition. An
important aspect to be analyzed is the meaning of HTX and
the need for chest drainage in different settings. Eggebrecht
et al.22 showed that patients with complex aortic pathol-
ogies were at higher risk of a poor outcome. In this study,
rupture of degenerative disease and traumatic rupture were
signiﬁcantly different populations, but the underlying pa-
thology had no impact on post-operative outcomes. These
data are supported by the study of Cambria et al.6 on
thoracic aortic catastrophes when outcomes were
controlled for baseline co-morbidities and age, the effect of
pathology was not signiﬁcant. This is not because traumatic
patients did worse, rather, the explanation lies in the
different risk proﬁle of the two groups: most of the trau-
matic ruptures occurred in younger patients, whereas pa-
tients with ruptures of degenerative disease were older and
with multiple more severe co-morbidities. Hence, despite
the less severe pre-operative condition, the latter group
included more fragile patients who beneﬁted from an
equally aggressive drainage of HTX.
An interesting issue to be debated is how often there is
rupture after acute type B dissection. This is not a rare
event, and has been associated with a higher operative
mortality than those with other types of complications.26e
29 The 14% in this study is less than the 23.1e60% re-
ported in different types of studies, but it is similar to the
15.2% reported by Cambria et al.,6 who also included all
types of thoracic aortic ruptures.26e29
It has been demonstrated that when lysis of chest he-
matomas is incomplete, by the 7th day HTX may adhere to
the lung and pleura, making it difﬁcult to remove, and
leading to respiratory complications or infection.30 There-
fore, clotted HTX should be considered for evacuation
within a reasonable time; currently, it is still unclear
whether, when, and how to perform chest drainage. A
recent paper by Bradley et al.31 showed that the volume of
retained HTX was not predictive of post-operative respira-
tory complications. Shu et al.9 drained the chest according
to the amount of HTX speciﬁcally to improve respiratory
function and obtained resolution in all cases. These expe-
riences analyzed only speciﬁc populations such as non-aorta
related trauma patients or dissections, did not use a speciﬁc
timing algorithm or volume limit for HTX evacuation, or
report the respiratory outcomes. All these data underscore
the lack of uniformity in current practice for HTX manage-
ment. This potentially also applies to this study, because
40% of the cases were drained. Nevertheless, the policy wasto drain the chest promptly in the post-operative period,
especially for the greater HTX thickness (> 3 cm) and in
patients with a respiratory index < 200. Certainly, the
compared groups are not similar, but such an aggressive
approach in this subset of patients may have contributed to
limiting the number of the most severe (SVS grade 2 or 3)
respiratory complications and overall mortality. The inci-
dence of respiratory complications after TEVAR for thoracic
aortic rupture has been reported in the range of 15e
39%.2,4,5,22,25 A recent nationwide study on use and out-
comes of TEVAR for ruptured thoracic aortic aneurysms
reported that respiratory complications were alarmingly
high at 63%, and even higher in the TEVAR group compared
with conventional repair.3 However, when pleural effusion
or HTX were eliminated from the ﬁnal analysis the respi-
ratory complications were lower in the TEVAR group. None
of these studies used a speciﬁc deﬁnition or analyzed the
respiratory complication rate after TEVAR. The 41% re-
ported in this study was higher than previously reported,
but all types of respiratory complication should be included
in accordance with the SVS guidelines.20
Limitations of the study
The multicenter design of this study has several limitations.
The number of patients remains relatively small for adequate
analysis and multivariate adjustment. Another important
limitation was the retrospective design. Finally, owing to
missing worldwide accepted guidelines, indications for the
management of the retained HTX may have affected the
results. However, due to the rarity of these events and its
emergent nature, it will be very difﬁcult to ever present a
large and homogeneous study. Despite these limitations,
there are no similar studies in the literature: the major crit-
ical aspect of the paper is the inability to present general-
izable conclusions, but this cohort of patients with HTX due
to thoracic aortic rupture treated with TEVAR is currently the
largest available, and may lead to larger studies to outline
the best management of this condition.
CONCLUSION
This study conﬁrms that descending thoracic aortic rupture
still carries a high mortality even in the TEVAR era; in
addition, respiratory complications have not been elimi-
nated by this less traumatic technique.
Prompt HTX evacuation may have contributed to limiting
post-operative mortality in drained patients who presented
with signiﬁcantly worse pre-operative respiratory parame-
ters. Although traumatic and degenerative ruptures are two
signiﬁcantly different scenarios, survival and respiratory
outcomes were not affected by the underlying aortic
disease.
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